KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insulet (PODD) EBIT Margin (2016 - 2026)

Insulet filings provide 16 years of EBIT Margin readings, the most recent being 18.67% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 37.0% to 18.67% in Q4 2025 year-over-year; TTM through Dec 2025 was 17.5%, a 259.0% increase, with the full-year FY2025 number at 17.5%, up 258.0% from a year prior.
  • EBIT Margin hit 18.67% in Q4 2025 for Insulet, up from 16.66% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 20.89% in Q4 2023 to a low of 8.92% in Q2 2022.
  • Median EBIT Margin over the past 5 years was 12.88% (2021), compared with a mean of 11.83%.
  • Biggest five-year swings in EBIT Margin: soared 1912bps in 2021 and later tumbled -1904bps in 2022.
  • Insulet's EBIT Margin stood at 16.15% in 2021, then crashed by -61bps to 6.36% in 2022, then skyrocketed by 229bps to 20.89% in 2023, then decreased by -12bps to 18.29% in 2024, then grew by 2bps to 18.67% in 2025.
  • The last three reported values for EBIT Margin were 18.67% (Q4 2025), 16.66% (Q3 2025), and 18.66% (Q2 2025) per Business Quant data.